Kenji Kabashima
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 713 publications
Uniform repigmentation following difamilast treatment for vitiligo.
Journal: European journal of dermatology : EJD
Published: September 06, 2026
Response to letter to the editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: August 04, 2026
Initial OX40-OX40L Signaling Promotes a Skin-Resident Memory T-Cell Reservoir in Atopic Dermatitis.
Journal: Allergy
Published: July 06, 2026
Author Correction: Atopic dermatitis.
Journal: Nature reviews. Disease primers
Published: June 19, 2026
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: May 21, 2026
The CCL20-CCR6 axis predominantly drives IL-17-mediated psoriasis while modestly contributing to papain-induced type 2 inflammation.
Journal: International immunology
Published: April 20, 2026
Corrigendum to 'Plasma proteomic profiles of patients with atopic dermatitis with moderate-to-severe pruritus treated with a single dose of nemolizumab' JID Innovations, Volume 6, Issue 3, May 2026, 100457.
Journal: JID innovations : skin science from molecules to population health
Published: April 20, 2026
Non-communicable inflammatory skin diseases comprise clinically meaningful distinct endotypes as identified by non-hypothesized integration of phenotypic and transcriptome data.
Journal: The Journal of allergy and clinical immunology
Published: April 16, 2026
Dupilumab (DUPIXENT) for bullous pemphigoid.
Journal: Trends in pharmacological sciences
Published: April 16, 2026
Cytotoxic CD4+ T cells across aging: a conceptual framework for health, protection, pathology, and age-associated diseases.
Journal: International immunology
Published: April 10, 2026
Linear IgA/IgG Bullous Dermatosis With Atypical Mixed Linear and Granular Immune Complex Deposition.
Linear IgA/IgG Bullous Dermatosis With Atypical Mixed Linear and Granular Immune Complex Deposition.
Journal: The Journal of dermatology
Published: April 09, 2026
Last Updated: 09/26/2026